• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙丁胺醇对映异构体调节人支气管平滑肌细胞血小板激活因子的合成和受体信号转导。

Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.

机构信息

Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.

出版信息

Int Arch Allergy Immunol. 2012;158(1):18-26. doi: 10.1159/000330029. Epub 2011 Dec 28.

DOI:10.1159/000330029
PMID:22212397
Abstract

BACKGROUND

Racemic albuterol is a 50:50 mixture of the (R)- and (S)-enantiomers of albuterol. Its clinical efficacy resides in the (R)-enantiomer (levalbuterol). Studies have shown that (S)-albuterol induces human bronchial smooth muscle cell (HBSMC) proliferation via a pathway linked to platelet-activating factor (PAF), but the underlying mechanism by which (S)-albuterol augments PAF effects is not clear. In this study, we compared effect of levalbuterol and (S)-albuterol on PAF receptor (PAFr)-mediated signaling and PAF metabolism by HBSMCs after incubation with the albuterol isomers.

METHODS

PAF binding and inositol phosphate (IP(3)) release were studied on adherent cultured cells. PAFr protein expression was measured by Western blotting, PAF synthesis and catabolism were measured in membrane and cytosolic proteins of cells incubated with albuterol isomers.

RESULTS

Compared to control conditions, (S)-albuterol increased PAF binding by 70% after 30 min of preincubation and by 150% after 24 h of preincubation. Levalbuterol had no effect on PAF binding under both conditions. (S)-albuterol also augmented PAF stimulation of IP(3) release, while levalbuterol and the racemic mixture had no effect. WEB 2170, a PAFr antagonist, inhibited the ability of (S)-albuterol to increase PAF binding or stimulate IP(3) release. (S)-albuterol stimulated PAFr protein expression. With PAF metabolism, (S)-albuterol treatment augmented PAF synthesis, but significantly inhibited PAF catabolism.

CONCLUSIONS

Our data suggest that one mechanism by which (S)-albuterol stimulates HBSMC proliferation involves upregulation of PAFr-mediated effects including increased PAF synthesis and decreased PAF catabolism.

摘要

背景

消旋沙丁胺醇是沙丁胺醇的(R)-和(S)-对映异构体的 50:50 混合物。其临床疗效存在于(R)-对映异构体(左沙丁胺醇)中。研究表明,(S)-沙丁胺醇通过与血小板激活因子(PAF)相关的途径诱导人支气管平滑肌细胞(HBSMC)增殖,但(S)-沙丁胺醇增强 PAF 作用的潜在机制尚不清楚。在这项研究中,我们比较了左沙丁胺醇和(S)-沙丁胺醇对 HBSMC 孵育沙丁胺醇异构体后 PAF 受体(PAFr)介导的信号转导和 PAF 代谢的影响。

方法

研究了粘附培养细胞中的 PAF 结合和肌醇磷酸(IP(3))释放。通过 Western blot 测量 PAFr 蛋白表达,通过细胞孵育的膜和胞质蛋白测量 PAF 合成和分解代谢。

结果

与对照条件相比,(S)-沙丁胺醇在预孵育 30 分钟后使 PAF 结合增加 70%,在预孵育 24 小时后增加 150%。在这两种情况下,左沙丁胺醇对 PAF 结合均无影响。(S)-沙丁胺醇还增强了 PAF 刺激的 IP(3)释放,而左沙丁胺醇和外消旋混合物则没有作用。PAFr 拮抗剂 WEB 2170 抑制了(S)-沙丁胺醇增加 PAF 结合或刺激 IP(3)释放的能力。(S)-沙丁胺醇刺激 PAFr 蛋白表达。用 PAF 代谢,(S)-沙丁胺醇处理增加了 PAF 合成,但显著抑制了 PAF 分解代谢。

结论

我们的数据表明,(S)-沙丁胺醇刺激 HBSMC 增殖的一种机制涉及 PAFr 介导的效应上调,包括增加 PAF 合成和减少 PAF 分解代谢。

相似文献

1
Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.沙丁胺醇对映异构体调节人支气管平滑肌细胞血小板激活因子的合成和受体信号转导。
Int Arch Allergy Immunol. 2012;158(1):18-26. doi: 10.1159/000330029. Epub 2011 Dec 28.
2
Mechanisms by which S-albuterol induces human bronchial smooth muscle cell proliferation.沙丁胺醇诱导人支气管平滑肌细胞增殖的机制。
Int Arch Allergy Immunol. 2008;146(4):321-33. doi: 10.1159/000121466. Epub 2008 Mar 21.
3
Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma.左旋沙丁胺醇抑制人气道平滑肌细胞增殖:对哮喘治疗的意义
Int Arch Allergy Immunol. 2006;139(3):225-36. doi: 10.1159/000091168. Epub 2006 Jan 27.
4
Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle.血小板活化因子调节胎羊肺血管平滑肌中环核苷酸的活性。
J Pharmacol Exp Ther. 2007 Feb;320(2):728-37. doi: 10.1124/jpet.106.111914. Epub 2006 Nov 3.
5
An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.血小板活化因子受体拮抗剂可抑制不可分型流感嗜血杆菌和肺炎链球菌对暴露于香烟烟雾中的培养人支气管上皮细胞的黏附。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 25;11:1647-55. doi: 10.2147/COPD.S108698. eCollection 2016.
6
Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor.反向激动剂诱导的血小板活化因子受体信号传导及下调
Cell Signal. 2007 Oct;19(10):2068-79. doi: 10.1016/j.cellsig.2007.05.015. Epub 2007 Jun 13.
7
Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.肿瘤微环境中的人骨髓间充质干细胞促进卵巢癌进展:血小板激活因子的作用。
BMC Cancer. 2018 Oct 19;18(1):999. doi: 10.1186/s12885-018-4918-0.
8
Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.过表达血小板活化因子受体的转基因小鼠气道高反应性由阿托品敏感途径介导。
Am J Respir Crit Care Med. 2002 Jan 15;165(2):200-5. doi: 10.1164/ajrccm.165.2.2106131.
9
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.血小板活化因子(PAF)可诱导角膜新生血管形成,并上调内皮细胞中血管内皮生长因子(VEGF)的表达。
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2915-21. doi: 10.1167/iovs.04-0128.
10
Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.血小板活化因子受体的表达增强了异硫氰酸苄酯诱导的小鼠和人黑色素瘤细胞凋亡。
Mol Med Rep. 2015 Jul;12(1):394-400. doi: 10.3892/mmr.2015.3371. Epub 2015 Feb 18.

引用本文的文献

1
Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications.变应性鼻炎中的血小板活化因子(PAF):临床及治疗意义
J Clin Med. 2019 Aug 29;8(9):1338. doi: 10.3390/jcm8091338.
2
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.过敏性疾病的脂质介质:途径、治疗方法及新兴治疗靶点
Curr Allergy Asthma Rep. 2016 Jul;16(7):48. doi: 10.1007/s11882-016-0628-3.